HER2 Overexpression trials recruiting in New York

Fewer than 3 recruiting trials found.

All HER2 Overexpression trials nationally

1

Recruiting in New York

2

Cities with sites

Cities in New York

Lake Success 1New York 1

Recruiting trials in New York

A Study of a Selective ERBB2 Inhibitor (CGT4255), in Patients With Advanced Solid Tumors
NCT07361562 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · New York: Lake Success, New York

Get notified when new trials open

One email when new recruiting trials are added. Unsubscribe anytime.